Literature DB >> 33679907

Outcome of thrombolysis with streptokinase in patients with prosthetic valve thrombosis.

Shahid Abbas1, Naeem Hameed2, Shahbaz Ahmed Khilji3, Anjum Jalal4.   

Abstract

OBJECTIVE: To evaluate the outcome of thrombolysis in patients of prosthetic valve thrombosis.
METHODS: This retrospective analysis was conducted on data of 84 patients of prosthetic valve thrombosis who presented to emergency room of Faisalabad Institute of Cardiology between July 2017 to December 2019. The diagnosis of prosthetic valve thrombosis was based on clinical suspicion and bed side transthoracic echocardiography done by a consultant cardiologist. Fluoroscopy was done to confirm the diagnosis by observing immobile valve leaflet. The confirmed patients were then treated in emergency with streptokinase after taking an informed consent. Quantitative variables like age were summarized by mean and standard deviation. Qualitative variables like gender, successful thrombolysis, stroke, major bleeding, mortality or re-do surgery were summarized by frequency and percentage.
RESULTS: Mean age was 29 ± 6.36, years and there were more female patients (n=43, 51.25%) as compared to males (n=41, 48.8%). Among the 66 surviving patients thrombolysis was successful without any complications in 56 patients (66.7%). Thrombolysis was successful with minor complications in six patients (7.1%) and it failed to produce desired results in four patients (4.8%). In this study 18 (21.4%) patients died. The common complications included minor bleeding in four patients (4.8%) and major bleeding in 10 patients (12.0 %).
CONCLUSION: Thrombolysis produces reasonable success rate in cases of prosthetic valve thrombosis who are in functional class I or II. However, it has very high mortality rate in patients presenting with functional class III and IV. Copyright: © Pakistan Journal of Medical Sciences.

Entities:  

Keywords:  Anticoagulation; Prosthetic Valve Thrombosis; Rheumatic Heart Disease; Thromboembolism; Thrombolysis

Year:  2021        PMID: 33679907      PMCID: PMC7931292          DOI: 10.12669/pjms.37.2.3226

Source DB:  PubMed          Journal:  Pak J Med Sci        ISSN: 1681-715X            Impact factor:   1.088


  13 in total

1.  Thrombolytic therapy for prosthetic valve thrombosis: short- and long-term results.

Authors:  D Gupta; S S Kothari; V K Bahl; K C Goswami; K K Talwar; S C Manchanda; P Venugopal
Journal:  Am Heart J       Date:  2000-12       Impact factor: 4.749

2.  Prevalence of Subclinical Rheumatic Heart Disease in Eastern Nepal: A School-Based Cross-sectional Study.

Authors:  Nikesh R Shrestha; Prahlad Karki; Rajan Mahto; Keshar Gurung; Naveen Pandey; Krishna Agrawal; Martina Rothenbühler; Philip Urban; Peter Jüni; Thomas Pilgrim
Journal:  JAMA Cardiol       Date:  2016-04-01       Impact factor: 14.676

3.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  J Am Coll Cardiol       Date:  2014-03-03       Impact factor: 24.094

4.  Successful thrombolytic therapy after acute tricuspid-valve obstruction.

Authors:  I T Luluaga; D Carrera; J D'Oliveira; C G Cantaluppi; H Santin; L Molteni; R Ferreira; E Zwolinski
Journal:  Lancet       Date:  1971-05-22       Impact factor: 79.321

5.  Anticoagulation protocol and early prosthetic valve thrombosis.

Authors:  Sachin Talwar; Chandra Kanta Kapoor; Devagourou Velayoudam; Arkalgud Sampath Kumar
Journal:  Indian Heart J       Date:  2004 May-Jun

Review 6.  Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.

Authors:  S C Cannegieter; F R Rosendaal; E Briët
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

7.  Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Lung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-25       Impact factor: 4.191

8.  Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a randomized controlled trial.

Authors:  Ganesan Karthikeyan; Ravi S Math; Navin Mathew; Bhima Shankar; Mani Kalaivani; Sandeep Singh; Vinay K Bahl; Jack Hirsh; John W Eikelboom
Journal:  Circulation       Date:  2009-09-08       Impact factor: 29.690

9.  Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry.

Authors:  Ann T Tong; Raymond Roudaut; Mehmet Ozkan; Alex Sagie; Maie S A Shahid; Sergio C Pontes Júnior; Francesc Carreras; Steven E Girard; Samir Arnaout; Raymond F Stainback; Ravi Thadhani; William A Zoghbi
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

10.  Predictors of the outcome of thrombolytic therapy in prosthetic mitral valve thrombosis: a study of 62 events.

Authors:  András Nagy; Mónika Dénes; Mária Lengyel
Journal:  J Heart Valve Dis       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.